Harvard Bioscience Inc. (HBIO): Rentabilitas operasi

harvardbioscience.com (HBIO) - logo korporat

Geopolitical pressure and trade barriers are hindering the delivery of Harvard Bioscience (HBIO) scientific equipment to foreign markets. The operating margin trend demonstrates the current profitability of the business, where the value of -0.20 represents the latest figure. Stable demand from pharmaceutical laboratories and the share of consumables support margins, although reliance on university government budgets requires management to maintain strict control over operating expenses.

HBIO - Rasio bathi operasi Harvard Bioscience ing rentang 04.07.2022 - 19.11.2026

Harvard Bioscience - rincian analitis lan metrik utama (HBIO)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:HBIO, Harvard Bioscience, Inc.
Produk dadi Harvard Bioscience Inc.

The selection of high-quality issuers is based on the business's ability to generate a sustainable cash flow before interest and taxes. An analysis of the historical operating margin of Harvard Bioscience (HBIO) allows for an assessment of the monetization efficiency of high-tech developments in biochips and laboratory automation, demonstrating what portion of revenue remains available to Harvard Bioscience after covering all production costs.

Analisis pesaing Harvard Bioscience

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|Margin dodolan operasi TKNO|Margin operasi monogramorthopedics.com|Margin dodolan operasi STSS (Sharps Technology, Inc.)|Rasio bathi operasi INFU|Margin operasi UTMD (Utah Med)|Rentabilitas kegiatan operasi KORU Medical Systems Inc. (KRMD)|Nyxoah S.A - Margin operasi|Microbot Medical Inc. (MBOT) - Margin dodolan operasi|PDEX: Margin operasi|ZTEK - Rentabilitas kegiatan operasi|ELUT (elutia.com) - Margin operasi|Margin dodolan operasi Milestone Scientific Corp (MLSS)|Margin dodolan operasi NXGL (NEXGEL)|RVP - Rentabilitas dodolan operasi|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi